InvestSMART

Elixinol Wellness Limited (ASX:EXL)

ALERT: Price-sensitive ASX Announcement for EXL
Current share price for EXL : $0.007 -0.001 (-6.67%)+
Announcement
Release
21 Apr 2026 1:53PM
Price at Release
$0.008
Full Release
download
Summary
Elixinol Wellness Limited reported its financial performance for Q1 FY26, showing stable revenue year-on-year despite being the weakest quarter seasonally. The company achieved a revenue of $3.5 million and improved its gross margin to 45% due to a strategic shift towards higher-margin products. Operating costs decreased significantly, contributing to a second consecutive quarter of positive underlying operating cash flow. Elixinol's focus on premium brands resulted in strong e-commerce sales growth. The company remains optimistic about future growth, supported by new product launches and retail channel expansions.
Key Points
  • Q1 FY26 revenue of $3.5m, stable YoY
  • Gross margin improved to 45%
  • Strong e-commerce sales, especially Healthy Chef up 25% YoY
  • Operating costs down 29% YoY
  • Second consecutive quarter of positive underlying operating cash flow
  • Revenue growth expected from new product launches and retail channels
  • Cash balance at 31 March 2026 was $1.2 million
  • Related party payments include Director fees and executive remuneration
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.